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Two phorbol ester-inducible elements (PE2 and PE3) within the human T-cell receptor j gene enhancer each
contain consensus binding sites for the Ets and core binding factor (CBF) transcription factor families.
Recombinant Ets-1 and purified CBF bound individually to PE2 and I3E3, in which the Ets and core sites are
directly adjacent. In this report, we show that CBF and Ets-1 bind together to ,3E2 and IPE3 and that
Ets-l-CBF-DNA complexes are favored over the binding of either protein alone to PE2. Formation of
Ets-l-CBF-DNA complexes increased the affinity of Ets-l-DNA interactions and decreased the rate of
dissociation of CBF from DNA. Ets-1-CBF-DNA complexes were not observed when either the Ets or core site
was mutated. The spatial requirements for the cooperative interaction of Ets-I and CBF were analyzed by
oligonucleotide mutagenesis and binding site selection experiments. Core and Ets sites were coselected, and
there appeared to be little constraint on the relative orientation and spacing of the two sites. These results
demonstrate that CBF and Ets-i form a high-affinity DNA-binding complex when both of their cognate sites are
present and that the relative spacing and orientation of the two sites are unimportant. Ets and core sites are
found in several T-cell-specific enhancers, suggesting that this interaction is of general importance in
T-cell-specific transcription.

The Ets family of proteins represents a novel class of
DNA-binding factors (12, 23). The v-ets oncogene was
identified as part of the genome of the E26 virus (19, 22) and
has been shown to be derived from the chicken gene
encoding Ets-1. Other members of the Ets family, Ets-2,
Erg, Elk-1, and Elf-1 (4, 27, 28, 31, 37), were isolated on the
basis of sequence homology to Ets-1. Additional Ets family
members, E74, GABPat, and PEA3 (6, 17, 18, 40), have been
purified and cloned on the basis of their ability to bind to
specific DNA sequences. PU.1, the product of the Spi-1 (21)
gene, and Fli-1 (1) were identified at sites of integration of
either spleen focus-forming virus or Moloney murine leukemia virus (MLV). SAP-1 (7) was isolated by its ability to
form a ternary complex with serum response factor (SRF) on
DNA containing a serum response element (SRE), a property also shared by Elk-1 (13). All Ets proteins share
sequence homology over the 85-amino-acid Ets domain,
which is responsible for DNA binding (23) and which specifies the family.
The known DNA binding sites for Ets proteins share a
common purine-rich central motif, GGAA/T. Binding site
selection assays using Ets-1 have defined flanking nucleotides on either side of the core that also form part of the
high-affinity binding site (8, 23, 39). Binding sites for Ets
proteins have been identified in several viral and cellular
promoters and enhancers. Human T-cell leukemia virus type
I (HTLV-I), polyomavirus, and murine sarcoma virus all
have Ets binding sites within their promoters. Ets-1 and
Ets-2 have been shown to bind and transactivate the
HTLV-I long terminal repeat (3), PEA3 binds the polyomavirus Ets site (40), and Ets-1 has been shown to bind the
murine sarcoma virus enhancer (11). The stromelysin pro-

moter contains an Ets site and is activated by Ets-1 (36).
SAP-1 and Elk-1 have been shown to bind to the Ets-like site
adjacent to the SRE in thefos promoter (7, 13). Elf-1, but not
Ets-1, can bind the GGAA motif within the NF-AT site of
the interleukin-2 enhancer (34). Ets sites have been identified
within the T-cell receptor a chain (TcRa), and subsequently
the TcRI gene enhancers and these sites were shown to bind
to Ets-1 (14, 26).
It has been shown that variations in the flanking sequences
surrounding the central nucleotides can control the differential binding of Ets family members (23, 34). However, in
several instances, the binding of accessory proteins has been
shown to confer different binding specificities on Ets proteins. Thus, binding of SAP-1 and Elk-1 to an Ets-like site
adjacent to the SRE in the c-fos promoter has been shown to
be dependent on the presence of SRF bound to the SRE (7,
13). GABPot was copurified as a heterodimer with an ankyrin
repeat-containing protein (GABPj). GABPa binds only
weakly to the herpes simplex virus immediate-early promoter, except in the presence of GABP, (18, 32), which also
interacts with DNA. PU.i binds to a site in the immunoglobulin K enhancer and recruits a second factor (NF-EM5) to an
adjacent binding site (25); NF-EM5 binds DNA only in the
presence of PU.1 and its own binding site. Thus, a common
feature of Ets proteins may be that they bind to response
elements in conjunction with a second protein.
Several Ets-1 binding sites, including the two within the
TcR,B enhancer, are located close to a T/G-rich motif which
in the murine sarcoma virus enhancer (29) has been called
the core site. Recently a protein, called core binding factor
(CBF), which binds this core motif has been purified (16, 35).
We have shown that the core sites within the TcR, enhancer
bind to purified CBF in vitro (26). The close proximity of the
Ets and core sites within the two inducible elements ,E2 and
1E3 (originally referred to as T,B3 and T14 in reference 10) of
the TcRpi enhancer led us to investigate whether Ets-1 and
CBF could bind together to PE2. Here we show that both
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CBF and either Ets-1 or Ets-2 will bind to PE2 together and
that this binding is cooperative. We further show that
cooperative binding is relatively independent of the orientation and distance between the two sites.
MATERIALS AND METHODS
Proteins. Ets-1 was expressed from a chicken Ets-1 cDNA
clone which encodes the p54 form of Ets-1, the chicken
equivalent of the major form of Ets-1 found in human T cells
(3). The human c-ets-2 cDNA was cloned at the BamHI site
of the pVL941 transfer vector (Pharmingen). The recombinant Autographa califomnica nuclear polyhedrosis virushuman Ets-2 baculovirus was obtained from supernatant of
Spodoptera frugiperda Sf9 cells cotransfected with the
pVL941-h-c-ets-2 construct and a linearized A. californica
nuclear polyhedrosis virus DNA lacking the polyhedrin
gene, using the Pharmingen baculovirus kit as instructed by
the manufacturer. The Ets-1 and Ets-2 proteins used were
produced in baculovirus-infected insect Sf9 cells (3). CBF
protein was purified from bovine thymus as previously
described (35).
Oligonucleotides. All oligonucleotides were synthesized on
an Applied Biosystems 380A machine. Labelling was performed by end filling with avian myeloblastosis virus reverse
transcriptase in the presence of [3"P]dCTP. All radiolabelled
double-stranded oligonucleotides were purified from 7.5%
acrylamide gels. The sequences of oligonucleotides (upper
strand only) were as follows: 13E2, GATCCACAACAGG
ATGTGGTTlTGACAlTTA; ,E2M1, GATCCACAACATT
ATGTGGTTTGACATTTA; ,E2M2, GATCCACAACAGG
ATGTGAGATCTCATTlA; 1E3, GATCTGGGTGCCGGA
TGCGGTGAGTGTGGTTCTCATGATGCG; 1E3M2A, GA

TCTGGGTGCCGGATGCGGTGAGTGTAATTCTCAT
GATGCG; and 3E3M2B, GATCTGGGTGCCGGATGCAA
TGAGTGTGGTTCTCATGATGCG.
Electrophoretic mobility shift assays. Radiolabelled probe
(10 fmol) was incubated in a final volume of 12 PI with Ets-1,
Ets-2, or CBF in 40 mM KCl-5 mM MgCl2-0.05 mM EDTA,
with 2 ,ug of acetylated bovine serum albumin and 0.1 ,g of
poly(dI-dC) poly(dI-dC), for 20 min at 25°C. For Ets-1 and
Ets-2, 0.25 ,g of insect cell extract was used; for CBF, 0.5 PI
of purified protein was used. Where this protocol was varied,
the modifications are described in the relevant figure legend.
Complexes were separated by electrophoresis on 5% polyacrylamide gels in 0.25x Tris-borate-EDTA.
Binding site selection. A pool of double-stranded 94-mer
oligonucleotides with 50 bases of random sequence flanked
on either side by 22 bases of fixed sequence was used for
binding site selection. Twenty-two-base oligonucleotides
complementary to either flanking region were used to amplify selected DNA by PCR. The sequences of oligonucleotides used were as follows: BSSN50, CGTCCATCGATCTG

AATTCGAC(N)50CTGAAGCTTGACTG CAGTATCG;
BSSL, CGTCCATCGATCTGAATTCGAC; and BSSR, CG
ATACTGCAGTCAAGCTITCAG.
The binding site selection procedure was essentially as
previously described (24, 39). DNA-protein complexes were
selected by using an Ets-specific antiserum (3) in the presence of 50 ng of Ets-1-containing insect cell extract and 1 pl
of CBF. Complexes were isolated on protein A-Sepharose
(Pharmacia), and the DNA was eluted and amplified with
Taq polymerase (Promega) in the presence of [32P]dCTP.
The amplified DNA was gel purified, and 1 pg was used as
starting material for the next round of selection. After four
rounds of selection for Ets-1-CBF complexes with the
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Ets-specific antiserum, two further rounds were performed
by gel shift. The complexes were allowed to form and then
separated by gel electrophoresis, and the band corresponding to Ets-l-CBF was excised and amplified. The gel shift
selection was carried out in the presence of 25 ng of
competitor oligonucleotide containing an Ets site. After the
final round, amplified DNA was digested with EcoRI and
HindIII and ligated into pBluescript (Stratagene). Clones
were sequenced by the dideoxy-chain termination method,
using Sequenase (U.S. Biochemical). Selection with CBF
alone was carried out entirely by gel shift. When no shifted
band was visible, the area adjacent to an authentic CBFDNA complex was excised and the DNA was amplified as
described above. Three rounds of selection by gel shift were
carried out before cloning of the oligonucleotides.
Measurement of dissociation rates. The dissociation rates
of Ets-1-CBF together and Ets-1 or CBF alone were determined by electrophoretic mobility shift assay. Scaled-up
binding reactions with an excess of labelled PE2 were
allowed to reach equilibrium at 25°C for 20 min and then
transferred to ice, and the zero-time-point material was
removed and loaded onto a running gel at 4°C. A 50-fold
excess of unlabelled 1E2 was added, and aliquots of the
binding reaction mixture were loaded onto the gel at 20, 40,
and 80 s and 2, 3, 5, and 10 min. The retarded bands were
quantitated directly from the dried gel on an Ambis scanner.
The dissociation rate constant was calculated from the slope
of the plot of log (percent bound at t - percent bound at t =
infinity), where infinity = 10 min.
RESULTS
CBF and Ets-1 or Ets-2 bind together to 13E2. To determine
whether Ets-1 and CBF can bind to the same PE2 molecule,
recombinant chicken Ets-1 and purified CBF were incubated
with a radiolabelled 13E2 oligonucleotide and complexes
were analyzed by electrophoretic mobility shift assays.
Incubation of labelled 1E2 with Ets-1 generated a retarded
complex, the intensity of which increased with increasing
amounts of Ets-1 (Fig. 1, lanes 2 to 4). Incubation of ,E2
with CBF results in a complex of higher mobility than
Ets-1-PE2 complexes (lanes 10 to 12). To demonstrate
whether Ets-1 and CBF preferentially bind to the same 13E2
oligonucleotide, binding reactions were performed with a
fixed amount of CBF and with increasing amounts of Ets-1.
When Ets-1 was included in the binding reaction, a complex
of lower mobility than that generated with either Ets-1 or
CBF alone was observed (lanes 5 to 8). When this experiment was repeated with a fixed amount of Ets-1 and increasing amounts of CBF, an additional complex of the same
mobility was observed (lanes 13 to 16). When human Ets-2
was used in place of chicken Ets-1, a ternary complex was
also observed (lanes 17 to 19). Taken together, these data
demonstrate that Ets-1 or Ets-2 and CBF preferentially bind

together to PE2.
To investigate whether both DNA binding sites are necessary for cooperative binding of Ets-1 and CBF, mutational
analysis was performed. A mutant Ets site was created by
changing the G residues of the central GGA sequence (Fig.
2B, 1E2M1) (26). The core site was mutated by altering the
bases at the 3' end of the consensus sequence (Fig. 2B,
PE2M2) (26). Mutation of the Ets site did not affect CBF
binding (Fig. 2A, lane 1). However, no Ets-1 or Ets-l-CBF
ternary complexes were seen when Ets-1 was added to the
binding reaction (lanes 2 to 4). When a similar experiment
was carried out with the core site mutant, no binding of CBF
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FIG. 1. Cooperative binding of Ets-1 or Ets-2 and CBF to 1E2. Radiolabelled j3E2 oligonucleotide was incubated in the presence of
chicken Ets-1 (lanes 2 to 4 and 13), CBF (lanes 5 and 10 to 12), or Ets-1 plus CBF (lanes 6 to 8 and 14 to 16). In lanes 2 to 4 and 6 to 8, increasing
amounts of Ets-1 were used (0.05, 0.1, and 0.2 ,ul). In lanes 10 to 12 and 14 to 16, increasing amounts of CBF were used (0.1, 0.2, and 0.4
,u). In lanes 1 and 9, no protein was added; in lanes marked +, 0.2 ,ul of CBF or 0.1 ,ul of Ets-1 was added, as indicated. In lanes 17 to 19,
0.4 ,ul of human Ets-2, 0.2 ,ul of CBF, and 0.4 ,ul of Ets-2 plus 0.2 Ill of CBF, respectively, were added. Complexes were resolved by
electrophoresis through a 5% polyacrylamide gel. The specific complexes formed are indicated.

alone or ternary complex formation was observed (lanes 5 to
8). When the same amounts of Ets-1 and CBF as used in
lanes 2 and 6 were added to unmutated 3E2, the major band
observed corresponded to the ternary complex (lane 9).
Thus, the integrity of both DNA binding sites is required for
cooperative binding of Ets-1 and CBF to ,BE2 to generate a
ternary complex.
CBF binding to fE2 increases Ets-1 binding. A 50-fold
excess of unlabelled ,E2 or PE2M1 oligonucleotide, but not
,BE2M2, fully competed for the observed CBF binding to
labelled 3E2 (Fig. 3A, lanes 1 to 4). When Ets-1 alone was
used in place of CBF, virtually all specific complexes were
abolished by a 50-fold excess of ,BE2 or 13E2M2 but not

1E2M1 (lanes 5 to 8). These results demonstrate that mutation at one site of 13E2 failed to affect cognate binding to the
second site when either Ets-1 or CBF alone was used. To
determine whether either Ets-1 or CBF binding was increased by ternary complex formation, competition experiments were performed with a range of concentrations of PE2
and the mutants 13E2M1 (Fig. 3C, Ets site mutant) and
13E2M2 (Fig. 3C, core site mutant). The ternary complex
formed on 13E2 (Fig. 3B, lane 1) was competed for efficiently
by a 50-fold excess of ,BE2 (lane 2), although some residual
Ets-1 complex was seen. The same excess of PE2M1 (Ets
site mutant) competed for almost all of the ternary complex
(lane 6), and at 100-fold excess, the ternary complex was
completely absent. Therefore, there was little difference
between the competition with a core site for CBF when
bound to 1E2 alone or as part of the ternary complex. As
expected, this competitor did not interfere with Ets-1 binding, as a strong Ets-1 complex was detected even with a
400-fold excess (lane 9). In contrast, competition with a
50-fold excess of ,E2M2 had little effect on the ternary
complex (lane 10), and only a low level of competition was
seen with up to a 400-fold excess (lanes 11 to 13), as
evidenced both by the intensity of the ternary complex band

and by the small amount of CBF-3E2 complex seen with
increasing competitor. This lack of competition by 1E2M2
for Ets-1 within the ternary complex was not due to mutation
of the core site affecting the Ets-1 binding site (Fig. 3A).
Thus, we conclude that formation of the ternary complex
greatly increases the binding of Ets-1 to ,BE2.
Binding of Ets-1 decreases the rate of dissociation of CBF
from DNA. The ternary complex formed on PE2 by CBF and
Ets-1 was more resistant to competition by either an Ets site
or a core site alone than when only one of the proteins was
bound to DNA. One possible explanation for this observation is that the rate of dissociation of the ternary complex is
slower than that of either protein alone. To investigate this
possibility, binding reaction mixtures containing labelled
3E2 together with either Ets-1 or CBF alone or with both
Ets-1 and CBF were prepared. Binding was allowed to reach
equilibrium at 25°C for 20 min and then transferred to ice,
and an aliquot of each reaction mixture was loaded onto a
gel. A 50-fold excess of unlabelled P1E2 was then added, and
samples were removed from each reaction mixture and
loaded onto a running gel at specific times after addition of
competitor. The amount of retarded complex at each time
point was then quantitated from the dried gel. The decrease
in bound 1E2 probe over the time course of the competition
for each reaction is shown in Fig. 4. The half-life of the
CBF-,E2 complex was significantly less than that for either
Ets-1-,E2 or the ternary complex. The dissociation rate
constants for each of the three complexes are 1.4 x 10-2 S-1
for CBF alone, 0.45 x 10-2 s-1 for Ets-1, and 0.35 x 10-2
s 1 for Ets-1 plus CBF. Thus, binding of Ets-1 decreases the
rate of dissociation of CBF from 1E2, whereas only a small
difference between the dissociation rate constants for Ets-1
alone and the ternary complex was observed.
Cooperative binding of Ets-1 and CBF occurs on 13E3. P1E3
constitutes a second element within the TcR,B enhancer that
has also been shown to bind to both Ets-1 and Ets-2 as well
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FIG. 2. Cooperative binding of Ets-1 and CBF is dependent on the presence of both the Ets and core sites. (A) Radiolabelled mutant
oligonucleotides were incubated with Ets-1, CBF, or both proteins together. The Ets site mutant (,E2M1) was incubated with 0.4 ±l of CBF
(lanes 1 to 3) in the absence of Ets-1 (lane 1) and with 0.1 Ill (lane 2) or 0.2 pl (lane 3) of Ets-1. Lane 4 shows radiolabelled 1E2M1 incubated
with 0.2 pl of Ets-1 in the absence of CBF. The core site mutant (PE2M2) was incubated with 0.2 p,l of Ets-1 in the absence of CBF (lane
5) and with 0.2 Il1 (lane 6) or 0.4 pl (lane 7) of CBF. Radiolabelled 1E2M2 incubated with 0.4 pul of CBF alone is shown in lane 8. Formation
of Ets-1-CBF complexes with radiolabelled unmutated ,E2 oligonucleotide is shown in lane 9 (0.2 p,l of CBF plus 0.1 pl of Ets-1). Complexes
were separated on 0.5% polyacrylamide gels, and specific complexes are indicated. (B) Schematic representation of the oligonucleotides used.
The mutations to the Ets and core sites are described in reference 26.

as CBF (26). However, 3E3 contains two core sites as well
as a single Ets site. One core site is in the same position
relative to the Ets site as in ,BE2, where the two sites are
directly adjacent. The other is in the same orientation,

although the central GTGG is separated from the GGAT of
the Ets site by 9 bp (Fig. 5B). CBF or Ets-1 alone bound to
1E3 (Fig. 5A, lanes 1 and 2). Comparison of the mobility of
the complexes formed by CBF on PE3 with those formed on
3E3M2A and ,BE3M2B (mutations in each core site) failed to
reveal an additional complex, corresponding to the binding
of two CBF molecules to fE3 (lanes 1, 4, and 7). This result
indicates a lack of cooperativity of binding between CBF
molecules, in marked contrast to the situation with Ets-1 and
CBF binding. When both Ets-1 and CBF were included in
the binding reaction, a complex of slower mobility was seen
(lane 3), indicating cooperativity of binding of Ets-1 and
CBF. A similar pattern of binding was seen when each of the
core sites was mutated individually (lanes 4 to 6 and 7 to 9).
Both sites bound CBF (lanes 4 and 7), and both formed
ternary complexes with Ets-1 (lanes 6 and 9). Therefore, the
interaction of Ets-1 and CBF on DNA can occur not only
when their cognate sites are adjacent (as in 3E2 and
1E3M2A) but also when they are separated by 9 bp
(PE3M2B).
Coselection of Ets and core sites by binding site selection.
The observed cooperativity of binding of Ets-1 and CBF to
both of the ,E3 core site mutants (,BE2M2A and 1E3M2B;
Fig. 5) suggests that there was some flexibility in the
configuration of binding sites permissive for cooperative
binding. Therefore, the technique of binding site selection

used to investigate the distance and orientation requirements for cooperative binding of these two factors. For these

was

experiments, an oligonucleotide containing a central region
of 50 bases of random sequence flanked on either side by 22
bases of fixed sequence was used. Four successive rounds of
selection were carried out in the presence of both Ets-1 and
CBF (to select for ternary complexes), using an Ets-1specific antiserum, followed by two rounds of selection by
electrophoretic mobility shift. As shown in Fig. 6A, successive rounds of selection using the Ets-specific antiserum
resulted in the formation of a progressively stronger CBFDNA complex, indicating that core sites were selected using
this strategy.
Sequences selected by this technique were analyzed for
the presence of the central bases of Ets (GGAA/T) and core
(GC/TGG) sites. Ets sites preceded by a G and core sites
surrounded by G residues were excluded, as these sites
failed to bind Ets-1 or CBF (data not shown). All 115
sequences obtained contained at least one Ets site, and 86
contained at least one core site. The number of Ets and core
sites within each of these 86 sequences is shown in Fig. 6B.
Interestingly, 26 sequences contained adjacent Ets and core
sites of the configuration found in ,BE2 and 1E3. Of the
remaining 60 sequences with nonadjacent Ets and core sites,
50% contained a single Ets site plus a single core site (Fig.
6B). The sequences were separated into several groups for
detailed analysis of Ets and core binding sites.
PE2-like Ets and core sites. Those sequences containing a
,BE2-like sequence were analyzed separately because the
overlapping Ets and core sites might be expected to bias the
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on 5% polyacrylamide gels, and specific complexes are indicated. (C) Schematic representation of the oligonucleotides used as competitors.

derived for each site. When a consensus site was
derived from this group (Fig. 7A), there was no apparent
difference from the consensus Ets site derived previously (8,
23, 33, 39) or from the single Ets sites analyzed in this study
(Fig. 7B). In contrast, there was a subsite selection for core
sites within this group. As shown in Fig. 7A, there was a

consensus
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FIG. 4. Analysis of dissociation rates of Ets-1-,BE2, CBF-1E2,
and ternary complexes. Binding reactions were transferred to ice, a
50-fold excess of competitor ,BE2 (unlabelled) was added, and
aliquots of each reaction were loaded onto a running gel at defined
time points. Complexes were resolved on a 5% polyacrylamide gel
electrophoresed at 4°C. The amount of retarded probe in each
complex was quantitated and plotted against time.

clear preference for a T nucleotide within the GC/TGG in
core sites from PE2-like sequences, whereas a slight preference for C was observed in all other core sites selected (Fig.
7C and D). This strong preference for a T residue may reflect
the use of this residue in ,E2-like sequences by both Ets-1
and CBF, although we cannot rule out that this preference
arose as a result of the selection procedure. The high
frequency of 3E2-like sequences suggests that there is a
strong selection for this arrangement of Ets and core sites
when sequences are selected with Ets-1 and CBF.
Core sites selected with Ets-1 and CBF. The 49 clones
which contained single core sites that were not adjacent to
Ets sites were analyzed to derive a consensus core site. As
shown in Fig. 7C, there was strong selection for an A or a T
in the position preceding the first G of the core site and T
then A in each of the two positions after the four central
bases of the core site. The frequencies of both the most
common bases as well as the second-choice bases at each of
these positions were significant at >99.5% by chi-square
analysis. There was little statistically significant selection of
specific bases flanking this central region, although at position +3, there seemed to be a bias against C. The major
difference between these sequences and the core site consensus from the ,BE2-like group of sequences is the strong
(3:1) preference for GTGG cores in the ,E2-like group
compared with a slight preference for GCGG among the
others. These results demonstrate that core sites were selected with an Ets-specific antiserum from random sequence
in the presence of CBF and Ets-1, further supporting the idea
that CBF stabilizes Ets-1 binding.
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or

Determination of the sequence of the core site in the absence
of Ets-1. To determine the range of sequences to which
purified CBF can bind in the absence of Ets-1, the random
oligonucleotide was used with purified CBF alone. Binding
reactions were fractionated by electrophoresis, and bound
DNA was excised from a polyacrylamide gel. In the first
round, where no retarded band was visible, the region of the
gel where complexes would be expected to migrate (as
determined by reference to an adjacent CBF-DNA band)
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were selected from random DNA sequence, using an Ets-specific
antiserum in the presence of both Ets-1 and CBF. CBF (0.4 ,ul) was
incubated with radiolabelled oligonucleotide pools, either unselected (lane 1, round 0) or after two (lane 2) or four (lanes 3 and 4)
rounds of selection with an Ets-specific antiserum, Ets-1, and CBF.
The complex retarded by CBF is indicated. This complex was
competed for (lane 4) by the core site-containing oligonucleotide
(1E2M1). (B) The distribution of Ets and core sites in the selected
sequences after four rounds of antibody selection and two rounds of
selection by gel shift is summarized. The number of Ets sites per
oligonucleotide is indicated at the top, and the number of core sites
is indicated at the left. The number of oligonucleotides with each
combination of Ets and core sites is shown. Those oligonucleotides
with a PE2-like combination of Ets and core sites are excluded from
this analysis. A further 29 sequences which contained no obvious
core-like sequence were obtained. All of this group contained
multiple Ets sites.

was

excised, and DNA was eluted and amplified. In subse-

quent rounds, more intense CBF-DNA complexes were

observed. We analyzed 69 sequences for the central four
nucleotides of the core site, GC/TGG. Seven did not contain
recognizable core sites, 41 contained single core sites, and
the remaining 21 contained two or more. The 41 oligonucleotides with a single core site were used to generate consensus sequences for CBF binding (Fig. 7D). The selected
consensus was cTGC/TGGTT/CA/t, where nucleotides in
uppercase were significant at >99.5% and those in lowercase
were significant at >90%. There was a slight preference for
a C rather than a T in the center of the core site. This
consensus was in broad agreement with the core site consensus recently defined by Melnikova et al. (20). Compared
with the core site consensus obtained from the Ets-1-CBF
selection, the ratios of GCGG to GTGG were very similar
(with the exception of the PE2-like sequences).
Some differences were, however, noted in the positions
flanking the core. Most obviously, A residues were observed
at the -1 and + 1 positions with increased frequency when
selected in the presence of Ets-1. A residues at these
positions have been shown to result in poor CBF binding
(see Fig. 9). It is possible that these differences reflect
preferences for CBF-DNA interactions when binding cooperatively with Ets-1; alternatively, these differences may be
a consequence of the binding site selection strategy used; for
example, weak core sites may have been selected from
among the Ets binding sites enriched by the Ets-specific
antiserum.
Electrophoretic mobility shift analysis of nine of the
selected oligonucleotides derived from the CBF alone selection demonstrated that GC/TGG sites bind CBF unless
surrounded on both sides by G residues. Those with sequences closer to the consensus bound CBF more efficiently
(see Fig. 9; also data not shown).
Taken together, the results from the two selection procedures provide strong support for the conclusion that CBF
binding enhances Ets-1 binding.
The relative orientation and spacing of Ets and core sites are
flexible. When sequences with a single copy of each site were
analyzed, all four relative orientations of the two sites were
observed (Fig. 8). The distances separating the four central
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binding sequence derived from all 33 clones with a single Ets site not
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and CBF. Only oligonucleotides with a single core site were used.
(D) Selection was performed in the presence of CBF alone, complexes were selected by gel shift, and 69 were sequenced after three
rounds of selection. Of those sequences, 41 contained single core
sites. The consensus derived from oligonucleotides with a single
core

site is shown.

nucleotides of each site varied from 1 to 33 bp. These results
suggest that there are only very weak spatial constraints on
the interaction of these two proteins when bound to DNA.
Consistent with this conclusion are the results of electrophoretic mobility shift assays carried out on a selection of
these oligonucleotides. Cooperative binding was assessed by
the differential ability of an Ets site competitor (PE2M2) and
a core site competitor (1E2M1) to compete for binding of
or CBF alone and together in the ternary complex.
Cooperative binding was observed on all oligonucleotides
tested that contained both Ets and core sites. As shown in
Fig. 9, Ets-1-CBF cooperative binding occurred when the
two sites are separated by up to 33 bases. Thus, for oligonucleotide 30, the Ets-1 complex (Fig. 9A) was competed for
by the Ets site but not by the core site, and the CBF complex

Ets-1

was

competed for by the

core

but not by the Ets site (Fig.

9B). When both Ets-1 and CBF were included in the binding
reaction, Ets-1-DNA complexes were observed in the presence of the core site competitor, whereas in the presence of
the Ets site competitor, a complex of slower mobility was

seen (Fig. 9C). Thus, little competition for the Ets-1 within
the ternary complex was observed with use of a 100-fold
molar excess of an Ets site competitor. Similar results are
shown for four other selected sequences: the amount of
ternary complexes formed appears to be dependent on a
combination of the strengths of binding of Ets-1 and CBF
alone. For example, oligonucleotide 53 bound CBF very
weakly and Ets-1 strongly but formed a ternary complex
similar to that formed by oligonucleotide 30, which bound
CBF alone more strongly and Ets-1 more weakly. Therefore,
the ternary complex forms when the sites are separated by
up to tens of bases, the degree of cooperative binding of
Ets-1 and CBF being a function of a combination of the
strength of binding of both Ets-1 and CBF alone.

DISCUSSION
Within the human TcRI enhancer, two elements, 1E2 and
,BE3, form a functional subdomain that constitutes the major
determinant of both basal enhancer activity and phorbol
ester inducibility (26). PE2 and tE3 each contain a consensus Ets binding site, and sequences that share homology
with the core site of MLV and other lymphotrophic viruses.
Inducibility has been shown to be dependent on the Ets sites
alone, whereas both Ets and core sites are required for basal
activity, with the core site playing the major role. Both Ets-1
and Ets-2 have been shown to bind specifically to 1E2 and
jE3 in vitro, and both elements will bind purified CBF (26).
In PE2, the Ets and core sites are adjacent and may be
partially overlapping, whereas in PE3, in addition to the
region homologous to the adjacent Ets and core sites of jE2,
there is also a second core site separated from the Ets site by
nine nucleotides.
The experiments presented in this report demonstrate that
the interaction of CBF and Ets-1 together with DNA facilitates formation of a ternary complex, which is more stable
than when either protein alone binds DNA. This cooperative
interaction is not restricted to chicken Ets-1, since it was
also observed with human Ets-2 and CBF. Thus, inclusion of
Ets-1 or Ets-2 and CBF in the electrophoretic mobility shift
assays resulted in the appearance of a complex that migrated
more slowly than the Ets-DNA complex and considerably
more slowly than the CBF-DNA complex. The preferential
formation of the ternary complex in the presence of excess
probe DNA constitutes strong evidence that Ets-1-CBF
binding is cooperative. In agreement with this conclusion,
competition for the proteins in the ternary complex with an
Ets site-containing oligonucleotide was very inefficient, even
when a large excess (up to 400-fold) of competitor was used,
suggesting that the binding of Ets-1 to DNA is increased by
cooperative interactions with CBF. The stabilizing effect of
ternary complex formation on CBF binding as assessed by
competition with a core site-containing oligonucleotide was
much less striking. Specific DNA sequences appear to be
necessary for interaction of CBF and Ets-1 because destruction of either binding site abolishes cooperative binding.
Ternary complex formation affected the DNA binding
characteristics of CBF by decreasing the dissociation rate of
CBF from DNA by approximately fourfold. Therefore,
formation of the ternary complex appears to have different
effects on Ets-1 and CBF. The dissociation rate of CBF from
DNA is decreased; in contrast, the binding of Ets-1 to its site
is increased without greatly decreasing its off rate. Thus, the
increased Ets-1 binding in the presence of CBF may be
explained by an increase in the rate of association of Ets-1
and DNA in the presence of CBF. A plausible mechanism
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FIG. 8. Alignment of oligonucleotides containing one core and one Ets site from the Ets-1-plus-CBF selection. The Ets sites are boxed,
and the core sites indicated by arrows, which represent their orientation relative to the Ets site. The sequence between the two sites, plus
four bases on either side, is shown.

for this effect would be prior binding of CBF to its binding
site, followed by recruitment of Ets-1. Attempts to measure
association kinetics of Ets-1 and CBF to 3E2 have failed,
since maximal binding occurred within 15 s (data not
shown).
Cooperative binding of Ets-1 and CBF was also seen on
PE3, and mutation of each of the two core sites individually
demonstrated that both could take part in ternary complex
formation. This result demonstrated that the Ets and core
sites are not required to be adjacent, as they are in PE2, for
Ets-1 and CBF to bind cooperatively. In contrast, no evidence was obtained for cooperative binding of two CBF
molecules to 1E3.
This result led us to investigate further the spatial constraints on cooperative binding of Ets-1 and CBF, using the
technique of binding site selection to select for both Ets and
core sites in a pool of random sequences. Coselection of core
and Ets sites at a high frequency with an Ets-specific
antiserum, in the presence of Ets-1 and CBF, provided
further evidence that ternary complex formation is preferred
over binding of either Ets-1 or CBF alone. Analysis of the
relative orientation and spacing of the Ets and core sites in
oligonucleotides containing only one copy of each site
suggests that the interaction of Ets-1 and CBF is flexible.

The degree of ternary complex formation is dependent on a
combination of the strengths of binding of Ets-1 and CBF
when they bind alone. Thus, for example, ternary complexes
could efficiently form on a low-affinity core site and a
high-affinity Ets site. Similar results were recently obtained
for the interaction of SRF and Elk-1 on the SRE and an Ets
site (33). In this case, the position of the SRE was fixed and
complexes were selected by excising them from a gel. The
Ets sites selected were spaced over the 27 bases of variable
sequence adjacent to the SRE and were found in both
orientations relative to it. In the case of Ets and core sites,
which are not palindromic, there are four possible relative
orientations. All four were observed, with no obvious bias
toward any one.
Taken together, these two studies demonstrate that the
distance between an Ets site (binding Ets-1 or Elk-1) and the
binding site for an accessory protein (CBF or SRF) with
which it interacts cooperatively can vary extensively. In this
context, it has been shown that the interaction of Elk-1 with
SRF is via a region (B box) that is outside the DNA binding
domain. It has been proposed that this separation of the
DNA binding and protein interaction domains allows the
flexibility in the interaction of Elk-1 and SRF (33). It will be
interesting to determine the region of Ets-1 that interacts
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FIG. 9. Electrophoretic mobility shift analysis of oligonucleotides selected in the presence of Ets-1 and CBF. Oligonucleotides
were incubated with 0.2 pl of Ets-1 alone (A), 0.4 .1l of CBF alone
(B), or 0.2 ,ul of Ets-1 and 0.4 p.1 of CBF together (C). Complexes
were resolved by electrophoresis, and specific complexes are indicated. In panel C, Ets-1-DNA complexes have not been clearly
resolved from Ets-l-CBF-DNA complexes. The competitors used
were ,BE2M1 (C[core site containing]) and 3E2M2 (E[Ets site
containing]), at 100-fold molar excess. Competitors are the same for
all three panels. (D) The oligonucleotides used. The Ets sites are
underlined, and the core sites are shown in boldface.

with CBF and its relationship to the functional differences
between c-Ets-1 and v-Ets. Moreover, flexibility in the
spacing between DNA binding sites for interacting transcription factors may turn out to be a more general property of
transcriptional regulation.
Several Ets binding sites in viral and cellular enhancers
are situated close to consensus core sites. As shown in Fig.
10, there appear to be two groups of Ets and core sites within
the enhancers of the mouse and human TcRa and -1B genes.
The human PE2 (10, 26) element and its murine homolog,
m13E4 (30), contain one Ets and one core site, and the 3E3
(10, 26) and Ta2 (15) elements, along with their murine

sites as jE2 together with a second core site. Both core sites
appear to have been specifically conserved in each member
of this last group, and where they vary in sequence, the core
site is not disrupted. Thus, the Ets adjacent core site in
human 1E3 is GCGG where the other three have GTGG, and
of the second core sites, two are GCGG and two are GTGG.
The MLV enhancer also contains binding sites for Ets-1 and
CBF (29), and in the polyomavirus enhancer, the Ets (PEA3)
binding site is situated close to a core site that binds the
PEA2 transcription factor (2); however, neither of these
enhancers has spacings homologous to those of the TcRa
and -I enhancer elements. We propose, therefore, that
cooperative Ets-CBF binding also occurs in the TcRa,
MLV, and polyomavirus enhancers. Thus, it appears that
the Ets-core site combination constitutes a specific functional unit, which may be particularly important in the
regulation of transcription of T-cell-specific genes.
Several Ets-related proteins have recently been shown to
bind DNA in association with other proteins. These include
interactions of SAP-1 and Elk-1 with SRF (7, 13, 33) and the
Ets-related protein GAPBax with another polypeptide,
GAPB,B (32), as well as interactions between Ets-1 and SP1.
This latter interaction generates a complex which synergistically transactivates the HTLV-I long terminal repeat via
adjacent Ets and SP1 sites (9). In each case, high-affinity
binding of the Ets-related protein to DNA was observed only
in the presence of the other polypeptide. Thus, a general
property of Ets-related proteins may be that they require
interactions with other proteins for high-affinity binding to
DNA, and it has been proposed that specific protein-protein
interactions between members of the Ets family and differing
second proteins regulate target selection by Ets family
members (5). The results presented here extend this idea by
demonstrating that the same Ets protein, namely, Ets-1, can
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be directed to bind with high affinity to different enhancers,
dependent on interactions with different accessory proteins.
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